This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Zambon S.p.a.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Gianluigi Faiella
Introduction
Gianluigi Faiella is a notable inventor based in Verona, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations for respiratory conditions. His work focuses on creating effective inhalable compositions that can improve the quality of life for patients suffering from obstructive airway syndromes.
Latest Patents
Faiella holds a patent for a pharmaceutical composition containing budesonide and formoterol. This invention relates to drug formulations in dry powder form for administration by inhalation, specifically indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD). The composition includes a first powder consisting of budesonide, leucine, and lactose, along with a second powder of formoterol, leucine, and lactose, and a third powder of leucine and lactose. The formulation boasts a fine particle fraction (FPF) greater than 60% and a delivered fraction (DF) greater than 90%, showcasing its potential effectiveness in clinical applications. Faiella has 1 patent to his name.
Career Highlights
Gianluigi Faiella is associated with Zambon S.p.a., a company known for its commitment to innovation in the pharmaceutical industry. His work at Zambon has allowed him to focus on developing advanced therapeutic solutions that address critical health issues. Faiella's dedication to research and development has positioned him as a key player in the field of inhalation therapies.
Collaborations
Throughout his career, Faiella has collaborated with talented professionals, including Giovanni Caponetti and Loretta Maggi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to the advancement of pharmaceutical technologies.
Conclusion
Gianluigi Faiella's contributions to the pharmaceutical industry, particularly in the development of inhalable drug formulations, highlight his innovative spirit and commitment to improving patient care. His work continues to inspire advancements in respiratory therapies, making a significant impact on the health and well-being of individuals with obstructive airway conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile